<!DOCTYPE html>
<html lang="en"><head>
<script src="index_files/libs/clipboard/clipboard.min.js"></script>
<script src="index_files/libs/quarto-html/tabby.min.js"></script>
<script src="index_files/libs/quarto-html/popper.min.js"></script>
<script src="index_files/libs/quarto-html/tippy.umd.min.js"></script>
<link href="index_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="index_files/libs/quarto-html/light-border.css" rel="stylesheet">
<link href="index_files/libs/quarto-html/quarto-syntax-highlighting-e26003cea8cd680ca0c55a263523d882.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.6.39">

  <meta name="author" content="Seungjun, Lee">
  <title>Treat-to-Target or High-Intensity Statin in Coronary Artery Disease</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="index_files/libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="index_files/libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
  </style>
  <link rel="stylesheet" href="index_files/libs/revealjs/dist/theme/quarto-bbe7401fe57d4b791b917637bb662036.css">
  <link href="index_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="index_files/libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="index_files/libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="index_files/libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">

<section id="title-slide" data-background-image="base image.png" data-background-opacity="0.3" data-background-size="contain" class="quarto-title-block center">
  <h1 class="title">Treat-to-Target or High-Intensity Statin in Coronary Artery Disease</h1>
  <p class="subtitle">Lipid lowering with Tailored approach</p>

<div class="quarto-title-authors">
<div class="quarto-title-author">
<div class="quarto-title-author-name">
Seungjun, Lee 
</div>
</div>
</div>

</section>
<section>
<section id="introduction" class="title-slide slide level1 center">
<h1>Introduction</h1>

</section>
<section id="glossary_1" class="slide level2">
<h2>Glossary_1</h2>
<ul>
<li><strong>Coronary Artery Disease(CAD)</strong> : 관상동맥질환; 심장에 혈액을 공급하는 관상동맥이 죽상동맥경화증(atherosclerosis)와 같은 원인으로 인해 좁아지거나 막혀 심장 근육으로의 혈류가 줄어드는 질환군. <br><br></li>
<li><strong>Atherosclerotic Cardiovascular Disease(ASCVD)</strong> : 죽상동맥경화성 심혈관질환; 죽상동맥경화로 인해 발생한 심혈관 질환군으로 관상동맥질환(CAD), 뇌졸중(Stroke), 말초동맥질환(PAD), 장허혈 등을 포함. <br><br></li>
<li><strong>Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)</strong> : 주요 심혈관 및 뇌혈관 사건; 심혈관 및 뇌혈관계에서 발생하는 주요 부정적 사건을 결합한 복합 지표로, 사망, 심근경색(Myocardial infarction, MI), 뇌졸중, 재혈관화 (Revascularization)을 포함.</li>
</ul>
</section>
<section id="glossary_2" class="slide level2">
<h2>Glossary_2</h2>
<ul>
<li><strong>Statin</strong> : 스타틴; 간 내 콜레스테롤 합성 효소 (3-hydroxy-3-methylglutaryl coenzyme A)를 억제하여 혈중 LDL-C 농도를 낮추는 약물군. <br><br></li>
<li><strong>Low-density lipoprotein cholesterol(LDL-C)</strong> : 저밀도 지단백 콜레스테롤; 간에서 조직 말단, 혈관으로 운반되는 “나쁜” 콜레스테롤로 이 수치 감소가 주요 목적.</li>
</ul>
</section>
<section id="background_1" class="slide level2">
<h2>Background_1</h2>
<ul>
<li>ASCVD 환자군에서 statin으로 LDL-C 수치를 절대적으로 감소시킬 경우 주요 혈관 사건의 비례적 감소와 연관성이 있다고 밝혀졌다. <br><br></li>
<li>때문에, 현재까지의 연구결과로는 LDL-C를 낮추면 낮출수록 ASCVD 위험이 계속 줄었고, 여러 기관에서 <strong>초기 LDL-C를 50% 이상 강하게 감소시키는 것을 목표로 고강도 statin 사용을 권장</strong>하였다.(High-Intensity Statin) <br><br></li>
<li>그러나 최근 연구는 statin에 대한 반응은 <strong>개인차</strong>가 있으며, 지속적인 고강도 statin 치료는 <strong>근육, 간, 콩팥</strong>에 해로움을 밝혔다.<br><br></li>
</ul>
</section>
<section id="background_2" class="slide level2">
<h2>Background_2</h2>
<ul>
<li>이러한 부작용을 고려하여 중등도 강도 statin으로 시작하며, 이후에는 <strong>특정 LDL-C 농도에 도달하도록 처방할 때마다 약물 용량을 조절하는 대안이 (Treat-to-Target)</strong> 제시되었다.<br><br></li>
<li>그러나 이러한 대안은 RCT 연구로 충분히 평가되지 않았고, 두 치료법을 직접 비교한 (head-to-head) 연구가 없기 때문에 Treat-to-Target의 사용에 대한 근거가 부족하다.<br><br></li>
<li>따라서 저자들은 <strong>ASCVD 환자들의 이차 예방</strong>의 측면에서, <strong>treat-to-target이 high-intensity에 비해 비열등함( noninferior)</strong>을 검증하기 위해 <strong>LODESTAR</strong> trial을 시행하였다.</li>
</ul>
</section></section>
<section>
<section id="method" class="title-slide slide level1 center">
<h1>Method</h1>

</section>
<section id="study-design" class="slide level2">
<h2>Study design</h2>
<ul>
<li>Investigator-initiated, Prospective, Multicenter, Randomized, Open-label, Noninferiority trial <br><br></li>
<li>한국의 12개 기관에서 시행</li>
<li>임상적으로 ASCVD 고위험군인 CAD를 진단받은 19세 이상의 환자들 (안전형 협심증, 불안정 협심증, NSTEMI, STEMI)</li>
</ul>
</section>
<section id="randomization-and-procedures" class="slide level2">
<h2>Randomization and Procedures</h2>
<div class="panel-tabset">
<ul id="tabset-1" class="panel-tabset-tabby"><li><a data-tabby-default="" href="#tabset-1-1">Random</a></li><li><a href="#tabset-1-2">Statin intensity</a></li><li><a href="#tabset-1-3">Arms</a></li></ul>
<div class="tab-content">
<div id="tabset-1-1">
<ul>
<li>Treat-to-target, high-intensity 군에 4400명을 <strong>1:1 랜덤 배정</strong></li>
<li>각 군은 다시 복용할 statin 종류(rosuvastatin, atorvastatin)에 따라 <strong>1:1 랜덤 배정</strong>.</li>
<li>베이스라인 LDL-C 초기 농도, 당뇨병 여부, 급성 관상동맥 증후군에 따라 층화.</li>
</ul>
</div>
<div id="tabset-1-2">
<p>statin 강도는 2013 ACC/AHA 지침으로, - 고강도: Rosuvastatin 20mg or Atorvastatin 40mg - 중간 강도: Rosuvastatin 10mg or Atorvastatin 20mg</p>
</div>
<div id="tabset-1-3">
<ul>
<li>Treat-to-target 군의 치료 목표는 50mg/dL &lt; LDL-C &lt; 70mg/dL이며, 환자의 수치에 따라 강도를 상향, 유지, 하향. (titration)</li>
<li>이때, statin 복용 경험이 없다면 중간 강도로 시작하고, statin 외 지질강하제 복용은 권고하지 않음.<br><br></li>
<li>High-intensity 군은 LDL-C 수치와 무관하게 고강도 statin 을 지속해서 처방.</li>
</ul>
</div>
</div>
</div>
</section>
<section id="primary-endpoint" class="slide level2">
<h2>Primary Endpoint</h2>
<ul>
<li><strong>Major Adverse Cardiac and Cerebrovascular Event(MACCE)</strong><br><br></li>
<li><strong>Death</strong> (사망), <strong>Myocardial infarction</strong> (심근경색), <strong>Stroke</strong> (뇌졸중), <strong>Revascularization</strong> (관상동맥 재혈관화)의 합으로 평가한 복합지표.</li>
</ul>
</section>
<section id="secondary-endpoint-follow-up" class="slide level2">
<h2>Secondary Endpoint, Follow up</h2>
<ul>
<li>당뇨, 심부전, 심부정맥혈전증(DVT), 대동맥 시술 또는 수술, 말기 신질환, 백내장 수술 등 <br><br></li>
<li>추적 관찰 주기는 6주, 3, 6, 12, 24, <strong>36개월</strong>로 설정.</li>
</ul>
</section>
<section id="sample-size" class="slide level2">
<h2>Sample Size</h2>
<ul>
<li>각 군 3년 MACCE(primary) 누적 발생률을 12%로 가정. (연간 4%)</li>
<li>Noninferiority margin은 3.0%로 설정.</li>
<li>검정력은 80%로 설정.</li>
<li>단측검정 1종 오류 확률은 2.5%로 설정.</li>
<li>탈락율(추적 손실)은 15%로 가정. <br><br></li>
<li><strong>최종 4400명, 각 군 2200명</strong>이 필요.</li>
</ul>
</section>
<section id="statistical-analysis" class="slide level2">
<h2>Statistical analysis</h2>
<ul>
<li>범주형 변수 -&gt; N(%); Chi-square test or Fisher’s exact test</li>
<li>연속형 변수 -&gt; Mean ± SD OR Median(IQR); T-test or Mann-Whitney U test <br><br></li>
<li>Primary endpoint -&gt; Log rank test, Cox proportional-hazards regression <br><br></li>
<li>Noninferiority는 두 군 MACCE(primary) 누적발생률 차이의 단측 97.5% CI의 상한이 3.0% 미만일 때 선언.</li>
</ul>
</section></section>
<section>
<section id="results" class="title-slide slide level1 center">
<h1>Results</h1>

</section>
<section id="baseline-characteristic" class="slide level2">
<h2>Baseline characteristic</h2>
<ul>
<li>2016/09/09 ~ 2019/11/27</li>
<li>두 군의 <strong>Baseline characteristic은 유의미한 차이가 없었다.</strong></li>
<li>무작위화 당시 진단받거나 시술/수술받은 지 1년이 넘은 사람: 75% <br><br></li>
<li>고강도, 중간 강도 statin 치료를 받던 사람: 25%, 57%</li>
</ul>
</section>
<section id="flow-diagram-baseline" class="slide level2">
<h2>Flow diagram, Baseline</h2>
<div class="panel-tabset">
<ul id="tabset-2" class="panel-tabset-tabby"><li><a data-tabby-default="" href="#tabset-2-1">Diagram</a></li><li><a href="#tabset-2-2">Baseline</a></li></ul>
<div class="tab-content">
<div id="tabset-2-1">
<p><img src="LOADSTAR Figure 1.png"></p>
</div>
<div id="tabset-2-2">
<p><img src="LOADSTAR Table 1.png"></p>
</div>
</div>
</div>
</section>
<section id="lipid-lowering" class="slide level2">
<h2>Lipid lowering</h2>
<ul>
<li>Treat-to-target 군은 1, 2, 3년 째 각각 <strong>53%, 55%, 56%</strong>가 고강도 statin 처방.</li>
<li>Treat-to-target 군은은 titrations는 17%는 상향, 9%는 하향 조정, 73%는 유지.<br><br></li>
<li>High-intensity 군은 1, 2, 3년 째 각각 <strong>93%, 91%, 89%</strong>가 고강도 statin 처방받음.<br><br></li>
<li>Ezetimibe은 Treat-to-target 군에서 강하게 권고하지 않았음에도, 더 많이 사용.</li>
</ul>
</section>
<section id="lipid-lowering-1" class="slide level2">
<h2>Lipid lowering</h2>

<img src="LOADSTAR Figure 2.png" class="r-stretch"></section>
<section id="ldl-c-level" class="slide level2">
<h2>LDL-C level</h2>
<ul>
<li><strong>6주: Treat-to-target 군의 LDL-C 수치가 유의미하게 더 높았다.</strong> (69.6 mg/dL vs 66.8 mg/dL, P&lt;.001)</li>
<li><strong>전체 기간: 두 군의 LDL-C 수치에 유의미한 차이 없었다.</strong> (69.1mg/dL vs 68.4mg/dL; p=0.21)<br><br></li>
</ul>
</section>
<section id="endpoint" class="slide level2">
<h2>Endpoint</h2>
<ul>
<li>Primary: <strong>MACCE 누적발생률은 Treat-to-target 군에서 177명(8.1%), High-intensity 군에서 190명(8.7%)</strong>으로 나타났다. 절대 차이는 -0.6%pp, 97.5% CI 상한은 1.1pp, <strong>p-value는 &lt; 0.001</strong> 이므로 비열등성을 증명하였다. <br><br></li>
<li>Secondary: <strong>두 군간 유의미한 차이 없었다.</strong> Post-hoc analysis에서 신규 당뇨병 발생, 말기 신질환 등을 포함하는 복합 지표는 Treat-to-target(6.1%)가 High-intensity(8.2%) 보다 낮은 발생률을 보여, 적은 부작용성을 보여준다.(P=0.009) <br><br></li>
<li>주요 결과지표에서 두 전략의 비교 결과는 모든 하위 그룹에서 일관되게 나타났다.</li>
</ul>
</section>
<section id="ldl-c-and-endpoints" class="slide level2">
<h2>LDL-C and Endpoints</h2>
<div class="panel-tabset">
<ul id="tabset-3" class="panel-tabset-tabby"><li><a data-tabby-default="" href="#tabset-3-1">LDL-C level</a></li><li><a href="#tabset-3-2">Endpoints</a></li></ul>
<div class="tab-content">
<div id="tabset-3-1">
<p><img src="LOADSTAR Figure 3.png"></p>
</div>
<div id="tabset-3-2">
<p><img src="LOADSTAR Table 2.png"></p>
</div>
</div>
</div>
</section>
<section id="conclusion" class="slide level2">
<h2>Conclusion</h2>
<ul>
<li><strong>LODESTAR trial</strong>은 3년 동안 4400명의 CAD환자를 대상으로 follow-up을 진행한 결과, 전체 사망, 심근경색, 뇌졸중, 관상동맥 재혈관화를 고려한 <strong>MACCE(&amp; secondary endpoints)에서 treat-to-target strategy가 high-intensity strategy에 비해 열등하지 않음을 증명하였다.</strong></li>
</ul>
</section>
<section id="discussion_1" class="slide level2">
<h2>Discussion_1</h2>
<ul>
<li>Treat-to-target 군과 High-intensity 군의 <strong>고강도 statin 사용</strong>에는 큰 차이가 있었으나 (54% vs 92%) <strong>치료 성적</strong>은 차이가 없었다. <br><br></li>
<li>이는 treat-to-target strategy가 <strong>개인 환자의 약물 반응을 고려한 맞춤형 접근법</strong>임을 시사한다. 즉, 저강도 statin 요법에도 반응을 보이는 환자에게는 부작용을 감수하며 고강도 statin 요법을 사용할 필요가 없다.</li>
</ul>
</section>
<section id="discussion_2" class="slide level2">
<h2>Discussion_2</h2>
<ul>
<li>Secondary endpoint가 treat-to-target 군에서 낮게 나타난 경향은 <strong>treat-to-target strategy가 고강도 statin 요법의 부작용으로부터 비교적 안전함</strong>을 시사한다. <br><br></li>
<li>실제로 2013 ACC/AHA 지침에서 고정용량 용법을 권고한 후 부작용 때문에 고강도 statin 요법을 중단하는 경우가 많아졌고, 최근 가이드라인은 ezetimibe 등의 약물과의 병용 요법을 권장한다.</li>
</ul>
</section>
<section id="discussion_3" class="slide level2">
<h2>Discussion_3</h2>
<ul>
<li>다만 treat-to-target strategy에서 유의할 점은 다음과 같다.</li>
<li><strong>LDL-C 목표치를 적절히 고려해야 한다.</strong> 본 연구는 70mg/dL 이하를 기준으로 삼았지만, 최근 유럽에서는 55mg/dL 이하를 권고했다.</li>
<li><strong>LDL-C 목표치 도달이 어렵다.</strong> 본 연구의 LDL-C 목표치 도달율은 high-intensity와 비교했을 때 treat-to-target 군에서 항상 낮았다. (2년 시점 제외)</li>
<li><strong>LDL-C 목표치 도달까지 오래 걸린다.</strong> 이 때문에 target-to-treat 군의 statin 시작 강도 역시 초기 LDL-C 수치에 맞춰 조절하는 전략이 필요할 수 있다.</li>
</ul>
</section>
<section id="limits" class="slide level2">
<h2>Limits</h2>
<ul>
<li>의사가 statin 용법을 안 채로 치료를 시행했다. <strong>(open-label)</strong>.</li>
<li><strong>MACCE 누적발생률이 예상보다 낮아</strong> 충분한 검정력을 확보하지 못했을 가능성이 있다.</li>
<li><strong>MACCE 누적발생률이 낮아</strong> 비교가 어려울 수 있다.</li>
<li>CAD 환자만을 대상으로 했기 때문에, <strong>다른 환자군</strong>을 대상으로 한 추가 연구가 필요하다.</li>
<li><strong>LDL-C 목표치 도달율이 낮아</strong> 치료의 적절성이 의심된다. (제한적인 병용 요법)</li>
<li>3년의 추적관찰이 장기 효과를 비교하는 측면에서 짧았을 수 있다.</li>
</ul>

</section></section>
    </div>
  <div class="quarto-auto-generated-content" style="display: none;">
<div class="footer footer-default">
<p>LODESTAR</p>
</div>
</div></div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="index_files/libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="index_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="index_files/libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="index_files/libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="index_files/libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="index_files/libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="index_files/libs/revealjs/plugin/notes/notes.js"></script>
  <script src="index_files/libs/revealjs/plugin/search/search.js"></script>
  <script src="index_files/libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="index_files/libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'jumpToSlide': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.toggleScrollView(event)\"><kbd>r</kbd> Scroll View Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"5\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: 'c/t',

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'slide',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'default',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.9/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const onCopySuccess = function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "Copied!");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "Copied!");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      }
      const getTextToCopy = function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
        text: getTextToCopy
      });
      clipboard.on('success', onCopySuccess);
      if (window.document.getElementById('quarto-embedded-source-code-modal')) {
        const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
          text: getTextToCopy,
          container: window.document.getElementById('quarto-embedded-source-code-modal')
        });
        clipboardModal.on('success', onCopySuccess);
      }
        var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
        var mailtoRegex = new RegExp(/^mailto:/);
          var filterRegex = new RegExp('/' + window.location.host + '/');
        var isInternal = (href) => {
            return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
        }
        // Inspect non-navigation links and adorn them if external
     	var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
        for (var i=0; i<links.length; i++) {
          const link = links[i];
          if (!isInternal(link.href)) {
            // undo the damage that might have been done by quarto-nav.js in the case of
            // links that we want to consider external
            if (link.dataset.originalHref !== undefined) {
              link.href = link.dataset.originalHref;
            }
          }
        }
      function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
        const config = {
          allowHTML: true,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start',
        };
        if (contentFn) {
          config.content = contentFn;
        }
        if (onTriggerFn) {
          config.onTrigger = onTriggerFn;
        }
        if (onUntriggerFn) {
          config.onUntrigger = onUntriggerFn;
        }
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          if (note) {
            return note.innerHTML;
          } else {
            return "";
          }
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    

</body></html>